Clinical Trials FAQs

People choose to take part in clinical trials for scleroderma for many different reasons¹.

You may want to:

• advance research and improve care for future generations
• help other people who also live with scleroderma
• try new tests or treatments that aren’t widely available yet
• be monitored more closely during the trial
• get free healthcare linked to the study
• be paid for your time and commitment

Taking part in a clinical trial is always voluntary² and there is no right or wrong for getting involved.

Whatever motivates you, taking part can make a meaningful difference – both to your own care and to the lives of others³.

Researchers are finding lots of new ways to help make sure that getting involved in a clinical trial for scleroderma is easier than ever.

This can include:

• text message reminders⁴
• smartphone apps to help track symptoms and appointments⁵
• free transport to and from the clinic⁶
• home visits⁷
• online options⁸

Each clinical trial is different⁹, so it’s important to take time to consider what works best for you.

Yes. Clinical trials are carefully regulated, and each country has its own laws designed to protect the safety and rights of all the volunteers¹⁰.

While the specific rules may vary, all research must follow strict ethical standards and can only go ahead once they have been reviewed and approved by regulatory authorities¹¹.

These strict guidelines help to make sure that everyone taking part is treated safely, fairly and with respect¹².

In international trials, each country must follow its own regulations, but the study is designed to meet consistent global standards¹³.

This helps to make sure that all participants, regardless of location, are protected and treated fairly¹⁴.

Costs vary depending on the trial¹⁵. In many cases:

• The study sponsor covers trial-related treatments and tests
• Standard care may still be covered by your healthcare provider
• You may also be reimbursed for travel or other expenses

It’s always important to ask the research team what is covered before taking part.

Whether you get to meet other people on the trial depends on how the trial is organised. Some studies involve group visits, peer support, or shared sessions where you may meet other participants, while others are more private and individual¹⁶.

If you do meet other participants, you can usually stay in touch. However, this is not always encouraged, as it may influence how people report their experiences in the study. The research team will explain what is appropriate for your specific trial and guide you on this.

Every trial is different¹⁷, so it’s important to ask your research team how much interaction with other participants is involved.

You are usually encouraged to talk to trusted friends and family about the experiences you’re having on a clinical trial¹⁸.

However, you may be asked not to share specific details about the treatment or study procedures, especially if this could affect the trial’s results¹⁹.

Each clinical trial is different²⁰. The research team will speak to you about the specific confidentiality rules linked to the trial before you join.

In some trials, participants may get a placebo (a treatment with no active drug)²¹. If the treatment proves effective, researchers may²²:

• Offer the active treatment to all participants during or after the study ends
• Make it available through future studies or standard care

This depends on the type and stage of the trial, so it’s important to ask about this before you join.

You may find it reassuring to know that your safety will be carefully monitored, even after a scleroderma clinical trial has ended²³.

• Before the trial finishes, the research team will explain what to look out for and how to report any changes in your health that you think might be linked to the study²⁴.
• You will also be given contact details so you know who to reach out to if you have any concerns²⁵.After the trial finishes, some trials include follow-up appointments or check-ins, while others may not²⁶.
• Some clinical trials also involve a “final study visit” where the researchers may carry out a physical examination, laboratory tests or scans – or they may ask you to fill out a questionnaire²⁷.
• If you notice any changes in your health or new symptoms – whether it’s soon after the trial ends or months later – it’s important to tell your doctor or research team. Sharing this information will help researchers continue to monitor safety and better understand the treatment²⁸.

If you’re ever unsure or worried about anything after the scleroderma clinical trial has ended, the advice is always to get medical advice straight away²⁹.